‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA

Abstract

The COVID-19 pandemic caused much illness, many deaths, and profound disruption to society. The production of ‘safe and effective’ vaccines was a key public health target. Sadly, unprecedented high rates of adverse events have overshadowed the benefits. This two-part narrative review presents evidence for the widespread harms of novel product COVID-19 mRNA and adenovectorDNA vaccines and is novel in attempting to provide a thorough overview of harms arising from the new technology in vaccines that relied on human cells producing a foreign antigen that has evidence of pathogenicity. This first paper explores peer-reviewed data counter to the ‘safe and effective’ narrative attached to these new technologies. Spike protein pathogenicity, termed ‘spikeopathy’, whether from the SARS-CoV-2 virus or produced by vaccine gene codes, akin to a ‘synthetic virus’, is increasingly understood in terms of molecular biology and pathophysiology. Pharmacokinetic transfection through body tissues distant from the injection site by lipid-nanoparticles or viral-vector carriers means that ‘spikeopathy’ can affect many organs. The inflammatory properties of the nanoparticles used to ferry mRNA; N1-methylpseudouridine employed to prolong synthetic mRNA function; the widespread biodistribution of the mRNA and DNA codes and translated spike proteins, and autoimmunity via human production of foreign proteins, contribute to harmful effects. This paper reviews autoimmune, cardiovascular, neurological, potential oncological effects, and autopsy evidence for spikeopathy. With many gene-based therapeutic technologies planned, a re-evaluation is necessary and timely.

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

“…A study of more than 50,000 employees at a medical institution in the United States observed the incidence of the Omicron variant epidemic based on the number of vaccine doses received (0, 1, 2, 3, and 4 or more doses) over a period of 26 weeks and showed that the number of vaccines received was positively correlated with the cumulative incidence rate of COVID-19 [ 46 ]. Susceptibility to COVID-19 infection after multiple vaccinations may be enhanced by antibody-dependent enhancement [ 47 ], immune imprinting [ 39 , 48 ], and immunosuppression [ 25 - 27 ]. This can result in a risk of exposure to viral S-protein in addition to vaccine S-protein for the multiple-vaccinated.…”

Correlations betweenper capitagreen tea consumption and COVID-19 morbidity/mortality: comparing the strength before and after Omicron emergence

“…In spite of the development of numerous vaccines for the prevention of COVID-19 and approval of several drugs for its treatment, there is still a great need for effective and inexpensive therapy of this disease. Additionally, it should be mentioned that initial expectations regarding efficacy and safety of SARS-CoV-2 vaccines were, probably, exaggerated (see [13] for review). In this overall context, green tea catechins, are considered as promising because of their antiviral effects against SARS-CoV-2, while EGCG was reported as most effective (e.g.…”

The mRNA-LNP vaccines – the good, the bad and the ugly?

“…The SAEs reported with the mRNA-LNP platform are very diverse. The SAEs are likely caused by the combination of the mRNA-LNP vaccine components (103) and potentially by direct toxicity and biological action of the spike protein itself (104)(105)(106)(107)(108). Here, we will focus on SAEs likely mediated by the immune system.…”